3-Year overall survival | 3-Year disease-free survival | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Hemoglobin (non-anemic vs anemic) | 1.941 | 1.177-3.202 | 0.009 | 1.999 | 1.232-3.244 | 0.005 |
Tumor location (C vs U vs M vs L) | 0.936 | 0.720-1.218 | 0.623 | 0.883 | 0.686-1.136 | 0.333 |
Treatment modality (RT vs S + RT vs CRT vs S + CRT) | 0.795 | 0.615-1.027 | 0.079 | 0.874 | 0.697-1.096 | 0.244 |
TNM stage (I vs II vs III vs IV) | 1.767 | 1.240-2.519 | 0.002 | 2.052 | 1.431-2.945 | 0.000 |
T stage (T1 vs T2 vs T3 vs T4) | 1.409 | 1.017-1.952 | 0.039 | 1.543 | 1.125-2.116 | 0.007 |
Status of lymph node (negative vs positive) | 2.676 | 1.582-4.527 | 0.000 | 2.241 | 1.376-3.652 | 0.001 |